Trial Profile

A Phase Ib/II, Open-label, Multicenter Study of Oral HDM201 in Combination With Oral LEE011 in Adult Patients With Liposarcoma

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 23 Dec 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ribociclib (Primary) ; Siremadlin (Primary)
Indications Liposarcoma
Focus Adverse reactions; Pharmacokinetics; Proof of concept; Therapeutic Use
Sponsors Novartis Pharmaceuticals

Most Recent Events

17 Dec 2021 Results published in the Clinical Cancer Research
17 Jan 2020 Status changed from active, no longer recruiting to completed.
13 Jun 2019 Planned End Date changed from 28 Jun 2019 to 6 Sep 2019.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com